TuHURA Cost Of Revenue vs Net Income Analysis

HURA Stock

4.21 0.01 0.24%

TuHURA Biosciences financial indicator trend analysis is much more than just breaking down TuHURA Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TuHURA Biosciences is a good investment. Please check the relationship between TuHURA Biosciences Cost Of Revenue and its Net Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.

Cost Of Revenue vs Net Income

Cost Of Revenue vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TuHURA Biosciences Cost Of Revenue account and Net Income. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between TuHURA Biosciences' Cost Of Revenue and Net Income is -0.68. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income in the same time period over historical financial statements of TuHURA Biosciences, assuming nothing else is changed. The correlation between historical values of TuHURA Biosciences' Cost Of Revenue and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of TuHURA Biosciences are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Cost Of Revenue i.e., TuHURA Biosciences' Cost Of Revenue and Net Income go up and down completely randomly.

Correlation Coefficient

-0.68

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on TuHURA Biosciences income statement and represents the costs associated with goods and services TuHURA Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in TuHURA Biosciences financial statement analysis. It represents the amount of money remaining after all of TuHURA Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from TuHURA Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TuHURA Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.The current year's Enterprise Value is expected to grow to about 220 M, whereas Selling General Administrative is forecasted to decline to about 3.1 M.

TuHURA Biosciences fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Non Currrent Assets Other	Intangible Assets	Other Assets	Property Plant And Equipment Net	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Common Stock Shares Outstanding		-0.07	0.87	0.68	0.7	-0.45	0.44	-0.49	0.26	-0.09	-0.09	0.67	-0.06	-0.02	0.48	0.6	-0.09	-0.56	-0.05	-0.39	-0.59	-0.69	0.67	-0.04	0.74	-0.69
Total Assets	-0.07		-0.1	0.02	0.23	0.87	-0.89	-0.46	0.43	0.99	0.99	0.44	-0.48	0.56	0.48	-0.29	0.99	-0.18	0.44	0.22	-0.32	-0.04	0.46	0.67	0.15	-0.04
Short Long Term Debt Total	0.87	-0.1		0.27	0.41	-0.38	0.52	-0.6	0.48	-0.15	-0.15	0.63	-0.06	0.18	0.56	0.3	-0.12	-0.49	-0.17	-0.35	-0.53	-0.79	0.32	-0.11	0.82	-0.79
Other Current Liab	0.68	0.02	0.27		0.9	-0.25	0.12	-0.25	0.02	0.0	0.0	0.51	-0.28	-0.18	0.3	0.59	-0.02	-0.44	0.16	-0.23	-0.5	-0.14	0.84	0.01	0.21	-0.14
Total Current Liabilities	0.7	0.23	0.41	0.9		-0.01	-0.03	-0.61	0.45	0.19	0.19	0.77	-0.55	0.11	0.66	0.4	0.19	-0.65	0.13	-0.25	-0.78	-0.2	0.86	0.16	0.38	-0.2
Total Stockholder Equity	-0.45	0.87	-0.38	-0.25	-0.01		-0.93	-0.29	0.42	0.85	0.85	0.18	-0.6	0.6	0.34	-0.63	0.87	-0.07	0.23	0.21	-0.09	0.3	0.09	0.56	-0.17	0.3
Net Debt	0.44	-0.89	0.52	0.12	-0.03	-0.93		0.13	-0.2	-0.91	-0.91	-0.1	0.43	-0.38	-0.2	0.4	-0.9	0.01	-0.35	-0.25	0.05	-0.37	-0.24	-0.66	0.21	-0.37
Retained Earnings	-0.49	-0.46	-0.6	-0.25	-0.61	-0.29	0.13		-0.89	-0.37	-0.37	-0.83	0.59	-0.58	-0.95	0.06	-0.41	0.51	-0.24	-0.06	0.85	0.38	-0.42	-0.14	-0.48	0.38
Accounts Payable	0.26	0.43	0.48	0.02	0.45	0.42	-0.2	-0.89		0.36	0.36	0.74	-0.68	0.61	0.91	-0.29	0.41	-0.54	-0.02	-0.09	-0.76	-0.26	0.22	0.31	0.48	-0.26
Cash	-0.09	0.99	-0.15	0.0	0.19	0.85	-0.91	-0.37	0.36		1.0	0.38	-0.43	0.46	0.4	-0.28	0.99	-0.22	0.36	0.13	-0.28	-0.03	0.47	0.75	0.16	-0.03
Cash And Short Term Investments	-0.09	0.99	-0.15	0.0	0.19	0.85	-0.91	-0.37	0.36	1.0		0.38	-0.43	0.46	0.4	-0.28	0.99	-0.22	0.36	0.13	-0.28	-0.03	0.47	0.75	0.16	-0.03
Net Receivables	0.67	0.44	0.63	0.51	0.77	0.18	-0.1	-0.83	0.74	0.38	0.38		-0.56	0.45	0.84	0.14	0.41	-0.63	0.15	-0.21	-0.8	-0.49	0.69	0.31	0.62	-0.49
Non Current Liabilities Total	-0.06	-0.48	-0.06	-0.28	-0.55	-0.6	0.43	0.59	-0.68	-0.43	-0.43	-0.56		-0.52	-0.6	0.52	-0.46	0.59	0.12	0.25	0.52	-0.05	-0.35	-0.24	-0.02	-0.05
Other Current Assets	-0.02	0.56	0.18	-0.18	0.11	0.6	-0.38	-0.58	0.61	0.46	0.46	0.45	-0.52		0.53	-0.45	0.55	-0.03	0.19	0.22	-0.16	-0.11	-0.01	0.03	0.11	-0.11
Other Stockholder Equity	0.48	0.48	0.56	0.3	0.66	0.34	-0.2	-0.95	0.91	0.4	0.4	0.84	-0.6	0.53		0.03	0.44	-0.53	0.22	0.02	-0.84	-0.27	0.47	0.27	0.55	-0.27
Total Liab	0.6	-0.29	0.3	0.59	0.4	-0.63	0.4	0.06	-0.29	-0.28	-0.28	0.14	0.52	-0.45	0.03		-0.32	0.02	0.26	0.03	-0.18	-0.16	0.46	-0.09	0.34	-0.16
Total Current Assets	-0.09	0.99	-0.12	-0.02	0.19	0.87	-0.9	-0.41	0.41	0.99	0.99	0.41	-0.46	0.55	0.44	-0.32		-0.21	0.36	0.15	-0.28	-0.04	0.43	0.71	0.16	-0.04
Common Stock	-0.56	-0.18	-0.49	-0.44	-0.65	-0.07	0.01	0.51	-0.54	-0.22	-0.22	-0.63	0.59	-0.03	-0.53	0.02	-0.21		0.47	0.74	0.67	0.35	-0.56	-0.34	-0.49	0.35
Non Current Assets Total	-0.05	0.44	-0.17	0.16	0.13	0.23	-0.35	-0.24	-0.02	0.36	0.36	0.15	0.12	0.19	0.22	0.26	0.36	0.47		0.87	-0.15	0.05	0.25	0.0	-0.13	0.05
Non Currrent Assets Other	-0.39	0.22	-0.35	-0.23	-0.25	0.21	-0.25	-0.06	-0.09	0.13	0.13	-0.21	0.25	0.22	0.02	0.03	0.15	0.74	0.87		0.12	0.26	-0.24	-0.23	-0.37	0.26
Intangible Assets	-0.59	-0.32	-0.53	-0.5	-0.78	-0.09	0.05	0.85	-0.76	-0.28	-0.28	-0.8	0.52	-0.16	-0.84	-0.18	-0.28	0.67	-0.15	0.12		0.39	-0.65	-0.31	-0.53	0.39
Other Assets	-0.69	-0.04	-0.79	-0.14	-0.2	0.3	-0.37	0.38	-0.26	-0.03	-0.03	-0.49	-0.05	-0.11	-0.27	-0.16	-0.04	0.35	0.05	0.26	0.39		-0.31	0.0	-0.79	1.0
Property Plant And Equipment Net	0.67	0.46	0.32	0.84	0.86	0.09	-0.24	-0.42	0.22	0.47	0.47	0.69	-0.35	-0.01	0.47	0.46	0.43	-0.56	0.25	-0.24	-0.65	-0.31		0.46	0.44	-0.31
Net Invested Capital	-0.04	0.67	-0.11	0.01	0.16	0.56	-0.66	-0.14	0.31	0.75	0.75	0.31	-0.24	0.03	0.27	-0.09	0.71	-0.34	0.0	-0.23	-0.31	0.0	0.46		0.31	0.0
Property Plant And Equipment Gross	0.74	0.15	0.82	0.21	0.38	-0.17	0.21	-0.48	0.48	0.16	0.16	0.62	-0.02	0.11	0.55	0.34	0.16	-0.49	-0.13	-0.37	-0.53	-0.79	0.44	0.31		-0.79
Short Long Term Debt	-0.69	-0.04	-0.79	-0.14	-0.2	0.3	-0.37	0.38	-0.26	-0.03	-0.03	-0.49	-0.05	-0.11	-0.27	-0.16	-0.04	0.35	0.05	0.26	0.39	1.0	-0.31	0.0	-0.79

Click cells to compare fundamentals

TuHURA Biosciences Account Relationship Matchups

TuHURA Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	6.0K	14.8K	42.0M	46.3K	48.3M	50.8M
Total Assets	13.5M	6.4M	15.2M	4.4M	5.0M	7.5M
Other Current Liab	561K	6.1M	838.7K	1.7M	2.0M	1.2M
Total Current Liabilities	2.8M	7.2M	2.9M	3.6M	4.1M	2.6M
Total Stockholder Equity	10.6M	(747.8K)	12.3M	(1.6M)	(1.8M)	(1.7M)
Net Debt	(10.5M)	(4.9M)	(14.1M)	(1.3M)	(1.2M)	(1.2M)
Retained Earnings	(111.2M)	(49.5M)	(59.2M)	(88.5M)	(79.6M)	(83.6M)
Accounts Payable	2.2M	413.8K	1.9M	1.9M	2.1M	1.5M
Cash	10.5M	5.5M	14.3M	3.7M	4.2M	6.5M
Cash And Short Term Investments	10.5M	5.5M	14.3M	3.7M	4.2M	6.5M
Liabilities And Stockholders Equity	13.5M	6.4M	15.2M	4.4M	5.0M	7.5M
Other Current Assets	1.3M	135.1K	491.8K	493.8K	567.8K	582.5K
Other Stockholder Equity	106.8M	48.7M	71.4M	86.9M	99.9M	56.5M
Total Liab	3.0M	7.2M	2.9M	5.9M	6.8M	3.7M
Total Current Assets	11.8M	5.7M	14.7M	4.2M	4.8M	7.1M
Common Stock	11K	33K	4.5K	6.8K	6.1K	5.8K
Non Current Assets Total	1.8M	721.0K	452.3K	203.0K	233.4K	437.2K
Property Plant And Equipment Net	150K	617.1K	418.5K	203.0K	233.4K	305.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:

How To Invest In TuHURA

Details

Is TuHURA Stock a good investment?

Details

What is TuHURA Biosciences' Net Worth?

Details

Largest Pharmaceutical Products Companies

View

Largest Biotechnology Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.21)

Return On Assets

(0.91)

Return On Equity

(3.33)

The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TuHURA Cost Of Revenue vs Net Income Analysis

Cost Of Revenue vs Net Income

Cost Of Revenue vs Net Income Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income

TuHURA Biosciences fundamental ratios Correlations

TuHURA Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

TuHURA Biosciences fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt	+ 1.0	Other Assets
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Cash

Other Stockholder Equity	- 0.95	Retained Earnings
Net Debt	- 0.93	Total Stockholder Equity
Cash And Short Term Investments	- 0.91	Net Debt
Cash	- 0.91	Net Debt
Total Current Assets	- 0.9	Net Debt
Accounts Payable	- 0.89	Retained Earnings